The CEO of the biotech lobbying group BIO is on leave, a spokesman said, amid what people familiar with the matter say is a clash over the organization’s direction
The chief executive of the biotechnology industry’s top lobbying group in Washington is on leave, amid dissent within the organization about its direction and concern about its results, according to people familiar with the group.
“The BIO CEO is currently on leave,” a spokesman for the Biotechnology Innovation Organization said in response to inquiries from The Wall Street Journal. He declined to comment further.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WSJ News Exclusive | BAE, U.S. in Talks to Restart M777 Howitzer Production After Ukraine SuccessArms maker BAE said it was considering restarting production of the M777 howitzer, as the big gun’s performance on Ukrainian battlefields revives interest in the weapon
Consulte Mais informação »
WSJ News Exclusive | Medical-Device Maker Recalls Sterilization Containers Over Potential BreachesA medical-device maker issued a voluntary recall of containers that hospitals use to sterilize surgical instruments, after finding the potential for breaches that could lead to infections in patients
Consulte Mais informação »
BlackRock strikes back against Republicans who say investment firm has gone ‘woke’ for climateBlackRock, the world's largest money manager, is mounting a new defensive strategy amid fierce scrutiny by Republicans and accusations its CEO Larry Fink is pandering to 'woke' climate and social values.
Consulte Mais informação »